A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Recruiting · NCT07018752 · Registry updated 2026-02-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-02-11 | NCT07018752 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
| Bristol-Myers Squibb | 422 |
| iOnctura | 6 |
| The Lymphoma Academic Research Organisation | 20 |
20 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.